2HRA Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Revenue And EBIT RecoveryThe rebound in revenue and operating margin indicates that H&R has regained demand and operating traction after a weak 2025. If this improvement persists, stronger EBIT generation can support reinvestment, customer retention, and recovery in earnings over the coming quarters.
Specialty Product ExposureExposure to specialty refinery and chemical products serving multiple industrial applications gives H&R a more differentiated business mix than a pure fuels refiner. Product breadth across rubber, plastics and lubricants can support customer relationships and reduce reliance on one end-market.
Positive Operating Cash Flow And Equity BasePositive operating cash flow shows that the business is generating cash from operations, while the sizable equity base provides a meaningful capital cushion. Together, these resources can help fund operations and provide some resilience as the company manages cyclical industrial demand.
Bears Say
Very Thin Net ProfitabilityThe very small bottom-line margin leaves limited room to absorb weaker pricing, higher feedstock costs, or softer industrial demand. Even after the operating recovery, modest changes in costs or revenue could materially affect net income and weaken the durability of earnings.
Sharp Free-cash-flow DeclineThe steep decline in free cash flow shows that reported operating improvement is not translating consistently into cash available after investment needs. Persistently weak conversion could constrain debt reduction, shareholder distributions, and the company’s ability to finance growth internally.
Earnings Volatility And Higher LeverageA recent loss alongside higher leverage highlights financial sensitivity across the cycle. Greater borrowing increases the importance of sustaining the earnings recovery, because weaker profitability could reduce financial flexibility and make capital allocation more constrained over the next several quarters.
H&R GmbH & Co. KGaA News
2HRA FAQ
What was H&R GmbH & Co. KGaA’s price range in the past 12 months?
Currently, no data Available
What is H&R GmbH & Co. KGaA’s market cap?
H&R GmbH & Co. KGaA’s market cap is CHF252.40M.
When is H&R GmbH & Co. KGaA’s upcoming earnings report date?
H&R GmbH & Co. KGaA’s upcoming earnings report date is Nov 13, 2026 which is in 60 days.
How were H&R GmbH & Co. KGaA’s earnings last quarter?
H&R GmbH & Co. KGaA released its earnings results on Aug 14, 2026. The company reported CHF0.949 earnings per share for the quarter, beating the consensus estimate of CHF0.911 by CHF0.038.
Is H&R GmbH & Co. KGaA overvalued?
According to Wall Street analysts H&R GmbH & Co. KGaA’s price is currently same.
Does H&R GmbH & Co. KGaA pay dividends?
H&R GmbH & Co. KGaA does not currently pay dividends.
What is H&R GmbH & Co. KGaA’s EPS estimate?
H&R GmbH & Co. KGaA’s EPS estimate is 0.
How many shares outstanding does H&R GmbH & Co. KGaA have?
Currently, no data Available
What happened to H&R GmbH & Co. KGaA’s price movement after its last earnings report?
H&R GmbH & Co. KGaA reported an EPS of CHF0.949 in its last earnings report, beating expectations of CHF0.911. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of H&R GmbH & Co. KGaA?
Currently, no hedge funds are holding shares in CH:2HRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
H&R GmbH & Co. KGaA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
44.48%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.38%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
H&R GmbH & Co. KGaA
H&R GmbH & Co. KGaA is a German enterprise specializing in the production and distribution of chemical-pharmaceutical raw materials and precision plastic components, manufactured through injection molding. The company's operations are structured into three primary segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining division is responsible for manufacturing and supplying a diverse array of refined products, including paraffins, white oils, plasticizers, base oils, lubricants, and other specialized crude oil derivatives, as well as feedstocks and bunker fuels. Concurrently, the ChemPharm Sales segment focuses on the processing and commercialization of products such as plasticizers, wax emulsions, paraffins, and similar crude oil-based specialty items. The Plastics division is dedicated to the development, production, and sale of high-precision plastic parts tailored for industries like medical technology, automotive, and various other sectors. H&R's extensive product portfolio also encompasses petroleum jellies, different types of motor and process oils, cable filling compounds, ozone protection waxes, raw materials for the cosmetic and pharmaceutical sectors, mineral oils, and construction insulation materials. Founded in 1919 and headquartered in Salzbergen, Germany, the company transitioned its name to H&R GmbH & Co. KGaA in August 2016, having previously operated as H&R Aktiengesellschaft. It functions as a subsidiary of H&R Komplementär GmbH.